Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer
Investment led by T&J Meyer Family Foundation, joined by Varia Ventures, NW Angel Fund and other non-institutional investorsFinancing advances Combat’s HIVEC® HEAT FDA registration trial to change standard of care in BCG unresponsive NMIBC
PINCH announces two major new contract wins as business growth continues into 2026
PINCH is proud to announce two significant new contract wins, marking an exciting start to the year and reinforcing the company’s continued growth across workplace catering, hospitality and events.
Centauri Therapeutics granted FDA QIDP status for CTX-187 treatment of Gram-negative bacterial infections
Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infectionsQualified Infectious Disease Product designation awarded for the development of antibacterials and a
Eppendorf introduces SpinPro® centrifuge series to streamline life science research
New Eppendorf SpinPro® 6 R centrifuge maximises workflow efficiency with flexible, ‘smart’ designCentrifuge showcased in ‘on demand’ video of virtual live launchHamburg, Germany, March 9, 2026 – Eppendorf, a leading internat
Cytotrait secures £3M seed funding to address global food security and sustainable agriculture
Proprietary MOSS technology enables high-level, localised gene expression to overcome current challenges in crop engineeringInvestment round led by Northern Gritstone, with additional contributions from UK Innovation & Science Seed Fund and Northern Universities Ven
Mursla Bio accelerates US commercial deployment of EvoLiver through ABHI Programme
Provides structured US market access for EvoLiver FDA-designated liver cancer surveillance test across health systems, payors and clinical stakeholders
OBN Invites Life Science leaders to celebrate 20 years of BioTrinity
Featuring keynotes from: Steve Bates, Executive Chair at the Office for Life Sciences, Lawrence Tallon, CEO at the MHRA & Maria Koufali, Life Sciences Industry Director at the NIHR, click here
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings
SPT Labtech to develop an automated sample preparation platform for Illumina to further optimize the efficiency and benefits of genomic workflows in decentralized healthcare settingsBuilds on success of existing partnership including development of automated library pre
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of developmentData confirms dual mechanism of action, including activation of tissue repair pathways i
Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to target Gram-negative bacterial infectionsInvestment from the world’s largest venture capital fund focused exclusively on antimicrobial therapeutics and d
Loughborough University and Science in Sport (SiS) extend partnership in elite sport and performance nutrition
Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and Science in Sport (SiS) announces a renewed three-year partnership, strengthening the organisations’ long-standing collaboration across elite sport and performance nutrition.
Calla Lily Clinical Care and Merck announce strategic collaboration to advance intravaginal drug delivery platform
Enhancing patient treatment experience and care with a new self-administered solution for vaginal therapeuticsVersatile platform technology developed from a safe, award-winning, FDA-cleared medical deviceStrate
Carterra launches industry’s first 48-channel HT-SPR platform for advanced label-free biomolecular screening and characterization
· Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discovery
· Enables primary screening with high-resolution binding
SPT Labtech and BellBrook Labs introduce high-throughput screening platform for cancer research
· Automated workflow to be highlighted at SLAS 2026, 7-11 February, Boston
Eppendorf collaborates with Dubai Police to automate forensics laboratories
Access to automated instrumentation will enhance precision testing and improve analytical efficiency, streamlining criminal identification
Bio-Rad receives AOAC international validation for EZ-Check Listeria spp. and EZ-Check Listeria monocytogenes Testing Kits
HERCULES, Calif. — February 6 2026 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announces it has received validation from AOAC International for its EZ-Check Listeria spp.
Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays
Collaboration heralds new era of assay development in drug discovery
SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies
Validated, tissue-specific library enables customisable and controllable liver-targeted gene expression with high specificity and minimal off-target activity in muscle tissue
iXCells Biotechnologies and Rosebud Biosciences partner to advance organoid-based models for rare diseases
Expansion of iXCells’ iPSCore platform with integration of 3D human organoid expertise will enable evaluation of drug toxicity and tissue-specific responsesResponds to growing demand for scalable, patient-relevant human models to support translational decision-making in
Vortex Biotech opens new state-of-the-art laboratory at Manchester Science Park
Expansion accelerates the development of its non-invasive cancer diagnostic solutions
ProImmune introduces Mastering Immunity 2026 - Shanghai Symposium to address key immunogenicity challenges
Symposium brings together global leaders in immunogenicity to connect with China’s rapidly evolving pharmaceutical development landscape Speakers include thought leaders in biotherapeutics, complex peptide drug developers, and regulatory authoritiesIn-
SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT’s firefly platform
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud Validated methods support Twist FlexPrep™ UHT and Enzymatic Fragmentation Kit 2.0, enabling higher throughput and reproducibility in NGS library preparati
Axol Bioscience raises $2.8M to advance US expansion and product development
Financing led by US life sciences investor, BroadOak Capital Partners Investment to support expansion of US operations, product development, and cell manufacturing scale-upCambridge / Edinburgh, UK, 13th January 2026: Axol B
Optibrium appoints Dr Nathan Brown as Director of Science
Newly created role underscores commitment to customer-driven research and scientific excellence
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
Oversubscribed £2.5M seed round led by Ahren Innovation CapitalStrategic collaboration with o2h to progress drug discovery programmeCambridge, UK, 12 January 2026: OutSee, a genomics and drug discovery company pioneering a unique AI-ba